Caunt et al., 1969 - Google Patents
Neutralization tests with varicella-zoster virusCaunt et al., 1969
View PDF- Document ID
- 7876207805802554444
- Author
- Caunt A
- Shaw D
- Publication year
- Publication venue
- Epidemiology & Infection
External Links
Snippet
A technique for neutralization tests using varicella-zoster virus propagated in primary human thyroid cells is described. The level of neutralizing antibody following chickenpox does not usually exceed a titre of 1/40 and in adults many years after infection it may be very low …
- 238000006386 neutralization reaction 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Caunt et al. | Neutralization tests with varicella-zoster virus | |
| MOSLEY et al. | Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis | |
| De Jong et al. | Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D | |
| Melnick et al. | A new member of the herpesvirus group isolated from South American marmosets | |
| Gudnadóttir et al. | Virus isolated from the brain of a patient with multiple sclerosis | |
| Cradock-Watson et al. | Specific immunoglobulin responses after varicella and herpes zoster | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| Aboudy et al. | Subclinical rubella reinfection during pregnancy followed by transmission of virus to the fetus | |
| Wittmann et al. | Occurrence and reactivation of latent Aujeszky's disease virus following challenge in previously vaccinated pigs | |
| Hobson et al. | Virological studies in natural common colds in Sheffield in 1960 | |
| Michaels | Immunologic aspects of congenital rubella | |
| JPS6216933B2 (en) | ||
| Christopher et al. | An epidemic of acute hemorrhagic conjunctivitis due to coxsackievirus A24 | |
| ANDERSEN | Complement‐fixing and virus‐neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen | |
| Meguro et al. | Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties | |
| Bogger-Goren et al. | Mucosal cell-mediated immunity to varicella zoster virus: role in protection against disease | |
| Quinnan et al. | Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine | |
| Beutner et al. | Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans | |
| Sommerville | Epidemic Kerato-Conjunctivitis—an adenovirus infection | |
| Ueda et al. | Immunological relationship between herpes simplex virus and B virus | |
| Du Pan et al. | Attenuation of rubella virus by serial passage in primary rabbit kidney cells: III. Clinical trials in infants | |
| Andersen | The influence of complement on cytomegalovirus neutralization by antibodies | |
| Van Oirschot | In vitro stimulation of pig lymphocytes after infection and vaccination with Aujeszky's disease virus | |
| PLOTKIN et al. | An attenuated rubella virus strain adapted to primary rabbit kidney | |
| McCarthy et al. | Rubella |